[SLRX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 31.74%
YoY- 60.21%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 18 0 0 0 -
PBT -972 -1,424 -1,715 -882 -2,443 -3,877 -5,341 -67.78%
Tax 0 0 0 -0 -89 -120 -80 -
NP -972 -1,424 -1,715 -882 -2,443 -3,877 -5,261 -67.46%
Tax Rate - - - - - - - -
Total Cost 972 1,424 1,715 900 2,443 3,877 5,261 -67.46%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -4,928.44 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.76 -2.37 -3.27 -0.22 -0.65 -1.43 -2.20 -50.67%
EPS Diluted -0.76 -2.37 -3.27 -0.22 -0.65 -1.43 -2.20 -50.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.